EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Formulation Design, Optimization, and Evaluation of Solid Lipid Nanoparticles Loaded With an Antiviral Drug Tenofovir Using Box–Behnken Design for Boosting Oral Bioavailability

Sri Rekha M iD, Sangeetha S iD

Advances in Pharmacological and Pharmaceutical Sciences · 2024-01 · 2024 (1)

DOI: 10.1155/2024/5248746 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Pharmacological and Pharmaceutical Sciences, online erschienen am 30.12.2024. Verfasst von Sri Rekha M und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, SRM College of Pharmacy, SRMIST, Kattankulathur, Chennai, Tamil Nadu, India. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The current study aimed to improve the oral bioavailability of tenofovir (TNF), an antihuman immunodeficiency viral (HIV) drug, by integrating it into solid lipid nanoparticles (SLNs), an emerging lipid formulation.

Method

The suggested SLNs were generated utilizing the microemulsion process, using Compritol 888 ATO. A Box–Behnken experimental design was attempted to analyze the impact of critical quality attributes (CQAs), such as lipid and surfactant content and homogenization duration on response metrics such as particle size (PS) and percentage entrapment. The prepared SLNs were assessed for entrapment efficiency, zeta potential (ZP), PS, polydispersity index, and in vitro drug release. Moreover, ex vivo permeation tests employing goat intestinal sacs, solid‐state characterization by DSC and PXRD, surface morphology by SEM, and in vivo pharmacokinetic evaluation using albino Wistar rats were conducted.

Results

The research findings demonstrated that a formulation composed of 5.5% lipid and 2% surfactant had a comparatively smaller PS (449.90 ± 4.79 nm), a narrow size distribution (0.304 ± 0.004), and strong stability with an entrapment efficiency of 83.13 ± 6.34% and a negative ZP (−18.10 ± 2.35 mV). According to in vitro drug release experiments, first‐order kinetics were followed and 99% of the medication was released over the time course of 24 h. In albino Wistar rats, an in vivo pharmacokinetic analysis of the optimized formulation (F10) showed a 12.4‐fold improvement in bioavailability over pure TNF solution.

Conclusion

This study suggests the potential of SLNs in overcoming bioavailability issues, particularly low permeability, gut metabolism, and P‐gp efflux transport.

Schlagwörter

Stichwörter der Autor:innen

Compritol 888 ATOnanocarriersrisk assessmentsolid lipid nanoparticlestenofovir

Autor:innen und Institutionen

  • Department of Pharmaceutics, SRM College of Pharmacy, SRMIST, Kattankulathur, Chennai, Tamil Nadu, India.

ORCID-Profile: Sri Rekha M, Sangeetha S

Zitieren

APA

M, S. R., & S, S. (2024). Formulation Design, Optimization, and Evaluation of Solid Lipid Nanoparticles Loaded With an Antiviral Drug Tenofovir Using Box–Behnken Design for Boosting Oral Bioavailability. Advances in Pharmacological and Pharmaceutical Sciences, 2024(1). https://doi.org/10.1155/2024/5248746

Vancouver

M SR, S S. Formulation Design, Optimization, and Evaluation of Solid Lipid Nanoparticles Loaded With an Antiviral Drug Tenofovir Using Box–Behnken Design for Boosting Oral Bioavailability. Advances in Pharmacological and Pharmaceutical Sciences. 2024;2024(1). doi:10.1155/2024/5248746

BibTeX
@article{M2024,
  author = {M, Sri Rekha and S, Sangeetha},
  title = {Formulation Design, Optimization, and Evaluation of Solid Lipid Nanoparticles Loaded With an Antiviral Drug Tenofovir Using Box–Behnken Design for Boosting Oral Bioavailability},
  journal = {Advances in Pharmacological and Pharmaceutical Sciences},
  year = {2024},
  volume = {2024},
  number = {1},
  doi = {10.1155/2024/5248746}
}
Kostenlos starten →